Nirsevimab may offer infants stronger protection against severe respiratory syncytial virus than maternal vaccination, ...

Shared clinical decision-making assumes access that many families lack, risking lower vaccination rates, wider inequities, and harm to children and public health.

A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer vaccine research are converging into a new era of more precise, personalized, ...

GoodRx reports on tracking prescription fills for flu and COVID-19 treatments, revealing seasonal trends and insurance ...

The chair of a federal vaccine advisory panel charted a new course for the committee in a podcast released Thursday, ...

Amid a surprisingly severe flu season and a Covid-19 resurgence, those highly contagious respiratory illnesses are drawing ...

In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...

In 2025's third quarter, multiple large vaccine developers, including Pfizer and GSK, saw vaccine sales tick up globally ...

As the 'crunchy mom' movement swells, it is emblematic of a mainstream embrace of vaccine skepticism and a broader lack of ...

As the 'crunchy mom' movement swells, it is emblematic of a mainstream embrace of vaccine skepticism and a broader lack of ...

Recent changes to the national immunization schedules have raised questions and caused confusion that could complicate care ...

A study aimed to compare corneal topographic and specular microscopic parameters both before and after patients received the ...